MedPath
NMPA Approval

Erythromycin Ethylsuccinate Granules

国药准字H33021352

June 12, 2020

Drug Information

琥乙红霉素颗粒

颗粒剂

按C37H67NO13计算0.125g(12.5万单位)

化学药品

June 12, 2020

Company Information

Applicant Company

Manufacturing Company

浙江省平湖市穗轮工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

琥乙红霉素颗粒 - NMPA 批准文号 | MedPath